Examples of using Luminity in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Other information about Luminity.
Luminity is a gas and solvent for dispersion for injection or infusion.
What is the risk associated with Luminity?
If you are given more Luminity than you should.
Luminity has not been specifically studied in patients with hepatic impairment.
In two of these studies, Luminity was compared with placebo a dummy treatment.
Caution must be exercised when considering the administration of Luminity to these patients.
Luminity 150 microlitres/ml gas and solvent for dispersion for injection/infusion perflutren.
Doppler ultrasound measurements were performed with Luminity in conjunction with the pharmacokinetic evaluation of perflutren.
Luminity should only be administered to such patients after careful risk/benefit assessment.
Before activation(shaking) the contents of the vial, Luminity appears as a colourless, uniformly clear to translucent liquid.
The way Luminity is given and the dose depend on the technique being used for the echocardiography.
During echocardiography, the perflutren microspheres in Luminity reflect ultrasound waves differently from the surrounding tissues.
Luminity should not be administered by methods not specified in section 4.2 e.g. intra-arterial injection.
Tell your doctor if you are pregnant or breast-feeding and ask your doctor orpharmacist for advice before you are given Luminity.
The perflutren component of Luminity was rapidly cleared from the systemic circulation via the lungs.
Patients with unstable cardiopulmonary status should be monitored during and for at least 30 minutes following Luminity administration.
The Vialmix is not included in the Luminity pack but will be provided to healthcare professionals upon ordering the pack.
Three studies looked at its ability to enhance the image of the left ventricle, comparing the echocardiography scan before and after administration of Luminity.
Luminity should not be used in children and adolescents(under 18 years of age) as it has not been studied in these groups.
Serious immediate hypersensitivity reactions(eg: anaphylaxis, anaphylactic shock and anaphylactoid reactions, hypotension and angioedema)have been reported following the administration of Luminity.
Luminity is an ultrasound contrast agent that contains microspheres(tiny bubbles) of perflutren gas as the active substance.
Fundamental and non-linear imaging techniques(second harmonic, multipulse phase and/or amplitude modulation) using both continuous and triggered acquisition were utilised in clinical studies with Luminity.
The safety of Luminity in patients with right-to-left, bi-directional or transient right-to-left cardiac shunts has not been studied.
Abnormal respiration, heart rate changes and decreased activity were observed soon after intravenous injection of Luminity at doses 0.3 ml/kg in single and repeat-dose toxicity studies in rats and monkeys.
Luminity may be diluted with sodium chloride 9 mg/ml(0.9%) solution for injection or glucose 50 mg/ml(5%) solution for injection.
Luminity is a solution for injection or infusion(drip) into a vein that contains microspheres(tiny bubbles) of perflutren gas as the active substance.
Luminity is given to you before or during your ultrasound examination by healthcare professionals such as doctors who are experienced in this type of examination.
Luminity should not be used with fundamental imaging technique for stress echocardiography since efficacy and safety have not been established.
Before use, Luminity must be activated by shaking it using a mechanical device called Vialmix, which is supplied to doctors who need to prepare the medicine.